CoreComm Internet

Features

Make this your home page

EXPLAINER: What's known about JJ's vaccine and rare clots

A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca. The U. S. recommended that states pause giving the J&J vaccine on Tuesday while authorities examine six reports of the unusual clots, including a death, out of more than 6. 8 million Americans given the one-dose vaccination so far. But the small number of cases sparked concern because just last week, said...

Read More
 
CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.